2Makker J, Chilimuri S, Bella J N. Genetic epidemiology of irrita- ble bowel syndrome [ J ]. World J Gastroenterol, 2015,21 (40) : 11353.
3Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome[ J]. Clin Epidemiol, 2014,6:71.
4Lovell R M, Ford A C. Global prevalence of and risk factors for irritable bowel syndrome: a Meta-analysis[ J ]. Clin Gastroenterol Hepatol, 2012,10(7) :712.
6yon Elm E, Altman D G, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies [ J ]. J Clin Epidemiol, 2008,61 (4) :344.
7Chang L, Toner B B, Fukudo S, et al. Gender, age, soeiety, culture, and the patient's perspective in the functional gastrointes- tinal disorders [ J ]. Gastroenterology, 2006,130 ( 5 ) : 1435.
8Vandvik P O, Lydersen S, Farup P G. Prealenee, eomorbidityand impact of irritable bowel syndrome in Norway [ J ]. Scand J Gastroenterol, 2006,41 (6) :650.
9Talley N J, Zinsmeister A R, Melton L J. Irritable bowel syn- drome in a community: symptom subgroups, risk factors, and health care utilization[J]. Am J Epidemiol, 1995,142( 1 ) :76.
10Klinkenberg I, Sambeth A, Blokland A. Acetylcholine and at- tention[ J]. Behav Brain Res, 2011,221(2) :430.
